Oklo Inc. (NYSE:OKLO) is one of the top mid-cap stocks to own for decades, according to hedge funds. On July 1, Oklo Inc. (NYSE:OKLO) sentiments received a significant boost after the U.S. Department of Energy approved the Documented Safety Analysis for its Groves Isotope Test Reactor in Texas.

Approved under the DOE's Reactor Pilot Program, it marks an important milestone in the facility's final safety basis. It also comes on the heels of an earlier approval of the Preliminary Documented Safety Analysis. The two approvals pave the way for the Groves Isotope Test Reactor to move from the documentation phase and into the final pre-startup review.

Success in the startup review phase will pave the way for Oklo to receive and load nuclear fuel to conduct startup testing at the facility. The company is already targeting first criticality for Groves in July.

The Groves facility strengthens Oklo's isotope business, which seeks to enable a strong domestic supply chain for critical isotopes. It also positions the company to be a key supplier of isotopes for scientific research, space exploration, and national security applications.

Oklo Inc. (NYSE:OKLO) is an advanced nuclear technology company developing next-generation, fast-fission power plants designed to provide clean, reliable, and affordable energy.

While we acknowledge the potential of OKLO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Billionaire Cliff Asness' Top 10 Healthcare Stock Picks and 10 Best Stocks to Buy Now for Good Returns.

Disclosure: None. Follow Insider Monkey on Google News.